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Aims: Data on sleep at altitude are scant due to the limited availability of polysomnography. Therefore, we
investigated whether actigraphy might serve as a simple tool for monitoring sleep during altitude field studies.
Methods: Fourteen mountaineers participating in studies on dexamethasone prophylaxis of high altitude pul-
monary edema were monitored by actigraphy and polysomnography during 1 night at Zurich (490 m) and 4
nights at the Regina Margherita hut (4559 m). Total sleep time (TST) estimated by actigraphy was compared to
polysomnography and subjective sleep quality. Results: In 64 comparisons, mean differences – 2SD (bias – limits
of agreement) between actigraphy and polysomnography were 5 – 35 min for TST and 1 – 7% for sleep efficiency.
Correlations between subjective and polysomnographic estimates of sleep efficiency and sleep latency were
nonsignificant. Medians of nocturnal oxygen saturation were 96% at 490 m and 74%–81% during nights 1 to 4 at
4459 m (p < 0.05 vs. 490 m). Medians of polysomnographic TST were similar at 490 m (451 min) and 4559 m (377–
456 min during nights 1 to 4, p =NS) but the proportions of slow wave and REM sleep were reduced and
arousals were more common (p < 0.05 all instances). Conclusion: Actigraphy accurately estimates sleep efficiency
and duration. Due to its portability and simple use and the potential application over several weeks, it is a
convenient tool for investigating altitude effects on sleep during field studies.
Key words: Actigraphy, sleep disorders, hypobaric hypoxia.
Introduction
During altitude sojourns, travellers commonly per-ceive a poor sleep quality ( Jafarian et al., 2007) which has
been related to sleep fragmentation and a reduction of deep
sleep ( Anholm et al., 1992; Beaumont et al., 1996; Khoo et al.,
1996). Insomnia is one of the leading symptoms of acute
mountain sickness However, the effects of altitude on sleep
are still incompletely understood since the conclusions that
can be drawn from earlier studies are hampered by small
sample sizes, differences in protocols, settings (field studies
vs. simulated altitude), sleeping altitude, and confounding
effects of acclimatization and altitude-related illness. Con-
sidering the increasing popularity of mountain tourism and
the requirements for professional personnel to stay at high
altitude during mining operations, working at telescope
stations, and other tasks, more scientific data on the ef-
fects of altitude on sleep would be desirable. Unfortunately,
the technical complexity and logistic demands of poly-
somnography, the gold standard for investigating sleep, have
been major obstacles to a more comprehensive investigation
of sleep during altitude field studies. Therefore, a simple
technique for the evaluation of sleep in such settings would
be desirable. We reasoned that actigraphy might be a useful
tool for the evaluation of altitude-related sleep disturbances
because it is simple to use and unobtrusive and because ac-
tigraphic-derived sleep time strongly correlates with poly-
somnography in normals and in patients with various sleep
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disorders (Cole et al., 1992, Elbaz et al., 2002, Lichstein et al.,
2006). The aim of the current study was therefore to validate
actigraphy for the assessment of altitude-related sleep dis-
turbances in comparison to polysomnography. We tested the
hypothesis that actigraphy accurately estimates total sleep
time, sleep efficiency, and sleep latency in comparison to
polysomnography.
Materials and Methods
Participants
This study was part of a research project evaluating dexa-
methasone for prophylaxis of high altitude pulmonary edema
(HAPE). Otherwise healthy mountaineers who had experi-
enced at least one episode of HAPE during earlier altitude
sojourns (i.e., HAPE susceptible subjects), were recruited by
advertisement. Subjects with chronic or acute medical con-
ditions requiring medical treatment were excluded. Partici-
pants gave written informed consent and the study was
approved by the institutional ethics committee.
Protocol
Within 1 month after baseline evaluation in Zurich (490 m),
participants travelled to Alagna (1170 m), Italy, ascended to
Passo Salati (2971 m) by cable car and walked to the Gnifetti
hut (3610 m) within 2–3 hours to spend the night there. The
following morning, subjects climbed to the Regina Margherita
hut (4559 m) within 4–6 hours and stayed there for 4 nights.
According to the protocol for the evaluation of dexama-
thesone prophylaxis on HAPE, subjects were randomized to
either receive dexamethasone tablets 4 mg b.i.d. starting 24
hours prior to ascent and during the entire stay at 4559 m, or to
receive identically looking placebo tablets 24 hours prior to
ascent and dexamethasone starting in the evening of the sec-
ond day at 4559 m. Actigraphy and polysomnographies were
performed during one night in Zurich and during 4 successive
nights at 4559 m from approximately 22:00 to 06:00 h.
Measurements
Actigraphy. The actigraph (MSR, Henggart, Switzerland)
used in this study was specially designed for high altitude
field studies. It is contained within the case of a watch and is
worn at the wrist of the nondominant hand (Fig. 1). It incor-
porates an accelerometer (Type ADXL 202AE, Analogue De-
vices, Norwood, OH), a barometric pressure sensor for
estimation of altitude, and a thermometer for measurement of
local skin temperature (or environmental temperature if the
device is not worn). Acceleration was recorded at a sampling
rate of 256 Hz and with 12 bit resolution over the range of – 2
g. Values averaged over successive 1 min intervals (epochs)
were stored in the internal solid state memory along with
barometric pressure and temperature.
Synchronization of actigraphic and polysomnographic re-
cordings were achieved by recording a time stamp via event
buttons on both devices at the beginning and the end of the
measurement phase (Fig. 1). At the end of the studies, the
internal memory of the actigraph was downloaded to a per-
sonal computer and processed by specialized software to es-
timate sleep/wakefulness times. Rest epochs were assumed to
represent sleep and identified by an acceleration level below a
threshold of 300 arbitrary acceleration units. This level had
been found in previous analyses to best separate sleep from
wakefulness (unpublished data). Therefore, this threshold
was applied as default to all analyses. Visual inspection by an
investigator blinded to the polysomnographic data served to
verify whether any adjustments were necessary due to po-
tential artefacts or individual differences in activity levels.
However, no adjustments to the standard threshold level were
required in any of the recordings. For each night, the following
measures were determined: time in bed= time from lights-off
to lights-on; total sleep time= sum of all epochs with activity
below threshold; sleep efficiency= total sleep time/time in
bed; sleep latency= time from lights-off to the beginning of the
first three consecutive epochs with activity below threshold.
To evaluate whether the actigraph used in the current study
(MSR, Henggart, Switzerland) provided activity recordings
comparable to recordings by a device from another company
(Actiwatch Spectrum, Philips Respironics, Amsterdam, NL), a
technical comparison was performed between recordings
obtained with the two devices worn simultaneously on the
wrist of a volunteer during 72 hours.
To evaluate whether sleep times obtained by the software
developed for the current study were comparable to corre-
sponding values obtained by another commercially available
software (Actiware 5, Philips Respironics), recordings were
analyzed separately by the two softwares and estimated sleep
times were compared.
Polysomnography. Polysomnography was performed
with a portable, battery driven device (LifeShirt, Vivometrics,
Ventura, CA) ( Bloch et al., 2010; Brack et al., 2007;Clarenbach
et al., 2005). Recordings comprised a central EEG lead (C3A2),
EOG, submental EMG, rib cage abdominal motion by cali-
brated respiratory inductive plethysmography, pulse oxi-
metry, capnography of expired air, ECG, and body position.
Sleep stages and arousals were scored according to Re-
chtschaffen and Kales and the guidelines of the American
Academy of Sleep Medicine by an investigator blinded to ac-
tigraphy (American Academy of Sleep Medicine, 2007; Amer-
ican American Sleep Disorders Association Task Force, 1992;
Rechtschaffen et al., 1968). Apneas/hypopneas were defined as
a reduction of the inductive plethysmographic sum volume
signal to < 50% of the preceding 2 min baseline during ‡ 10 sec
(American Academy of Sleep Medicine Task Force 1999,
Thurnheer et al., 2001). Transient reductions in breathing am-
plitude to < 50% baseline for 5–10 sec were also scored as ap-
neas/hypopneas if they occurred as part of a periodic
breathing pattern with hyperventilation alternating with cen-
FIG. 1. Actimeter with integrated barometric pressure
sensor for estimating altitude. E = event buttons; C= con-
nector for data download to a computer.
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tral apnea/hypopnea for at least three consecutive cycles
(Bloch et al., 2010). Central apneas/hypopneas were distin-
guished from obstructive apneas/hypopneas by the absence of
rib cage-abdominal asynchrony or paradoxical motion. The
apnea/hypopnea index (AHI) was computed as the number of
events per hour of sleep and the oxygen desaturation index as
the number of > 3% dips per hour of sleep. Sleep study analysts
were blinded to actigraphic and clinical data.
Questionnaire and clinical examination
Each morning subjects were asked to estimate the time
spent awake until they fell asleep after lights off (subjective
sleep latency). They also estimated the total time spent awake
during the entire night for calculation of subjective sleep ef-
ficiency as time in bed minus time spent awake/time in bed.
Subjective sleep quality was evaluated by visual analogue
scales according to the Leeds questionnaire (Parrott et al.,
1978, Tarrasch et al., 2003). For each question listed below a
vertical mark had to be placed on a line 100 mm in length. If no
change was experienced compared to the usual sleep, the
mark had to be placed in the centre (at 50 mm). Perceived
changes were represented by the distance of the mark from
the centre with values < 50 mm (left of the center) indicating
worse, and > = 50 mm (right of the center) indicating better.
The following statements were rated: ‘‘Sleep was more rest-
lessness than usual/more restful than usual;’’ ‘‘There were
more periods of wakefulness than usual/fewer periods of
Table 1. Sleep Studies
R. Margherita hut, 4559m
Zurich, 490m Night 1 Night 2 Night 3 Night 4 P
Polysomnography N= 14 N = 14 N = 14 N = 13 N= 14 ANOVA
TIB, min 478
(452;500)
494
(487;501)
513
(479;525)
482
(373;499)
480
(464;515)
ns
TST, min 451
(428;459)
442
(440;474)
456
(432;479)
377{
(357;448)
433
(410;454)
<0.05
SE, % 95
(90;98)
91
(89;93)
95
(88;96)
90*
(88;93)
88
(81;94)
ns
Awake, % TIB 4
(2;9)
9
(7;10)
5
(4;11)
10*
(6;12)
12
(6;19)
ns
Wake after sleep onset, min 16
(8;35)
27
(9;38)
20
(11;54)
20
(16;46)
35
(8;62)
ns
Sleep latency, min 4
(2;9)
7
(3;28)
6
(3;9)
6
(4;10)
13*
(6;27)
ns
Stage 1+ 2, % TST 66
(57;73)
80*
(75;88)
85*
(76;88)
70
(69;85)
79*
(73;88)
< 0.02
Stage 3+ 4, % TST 18
(13;20)
7*
(4;10)
0*#
(0;0)
8{
(6;16)
5*{
(1;10)
< 10 - 5
REM, % TST 10
(7;14)
1*
(1;2)
0*#
(0;0)
2*{
(2;4)
1*{
(1;3)
< 10 - 5
Arousal index, 1/h 1.7
(1.0;4.1)
6.9*
(4.2;12.3)
4.1*
(2.3;9.0)
6.2*
(3.0;9.7)
6.0*
(2.9;9.2)
< 10 - 3
SpO2, % 96
(94;96)
74*
(73;78)
79*#
(76;80)
79*#
(76;82)
81*#
(77;83)
< 10 - 5
ODI ‡ 4%, 1/h 0.6
(0.4;1.3)
69.6*
(61.5;104.6)
43.2*#
(20.4;66.4)
16.2*#
(12.2;39.5)
33.3*#
(8.4;53.8)
< 10 - 5
AHI, 1/h 5.6
(1.3;6.9)
88.1*
(84.4;128.5)
61.9*#
(24.6;95.9)
32.7*#
(9.4;75.6)
42.4*#
(14.5;78.3)
< 10 - 5
PetCO2, mmHg 36.3
(35;38.1)
26.4*
(25.5;28)
24.9*
(24.2;26.8)
24.8*#{
(23.1;25.6)
24.2*#
(22.4;26.6)
< 10 - 5
Actigraphy n = 14 n = 12 n = 13 n = 12 n = 13
TST, min 464
(435;480)
458
(391;470)
462
(432;490)
415{
(356;453)
437
(408;456)
ns
SE, % 97
(94;97)
94
(91;96)
95
(88;96)
92*
(90;95)
90
(84;97)
ns
Awake, % TIB 4
(3;6)
7*
(4;10)
5
(4;12)
9*
(5;10)
10*
(3;16)
ns
Wake after sleep onset, minx 13{
(3;24)
18
(9;31)
21
(14;54)
27
(16;38)
42
(15;78)
ns
Sleep latency, 3 min algorithm 3
(2;5)
7
(4;10)
4
(3;5)
4
(3;7)
3{
(3;4)
ns
Sleep latency, 5 min algorithm 6
(4;7)
9
(5;12)
5
(5;10)
7
(5;11)
5
(5;6)
ns
Medians (quartiles). TIB, time in bed; TST, total sleep time; SE, sleep efficiency; *p < 0.05 vs. 490 m, #p< 0.05 vs. night 1, { p < 0.05 vs. night 2,
U p < 0.05 vs. night 3. { p < 0.05 actigraphy vs. polysomnography. x based on a sleep latency algorithm of 5 minutes.
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wakefulness than usual;’’ ‘‘How did you feel on waking
(tired/alert).’’
Symptoms of acute mountain sickness were assessed by the
Lake Louise protocol self report and clinical assessment
(Maggiorini et al., 1998). A Lake Louise total score ‡ 5 was
considered to indicate acute mountain sickness.
Data analysis
Data are summarized as medians and quartiles for non-
normally distributed data and as means– SD for normally
distributed data. Sleep parameters determined by poly-
somnography and actigraphy were compared graphically and
by computing the bias (mean difference) and limits of agree-
ment (– 2SD) (Bland et al., 1986). Correlations between the two
methods were performed by the Spearman Rank Order testing.
The effects of altitude were evaluated by Friedman ANOVA
followed by Wilcoxon matched pairs tests as appropriate. A
probability of p< 0.05 was considered significant.
Results
Subjects
Twenty-three subjects were recruited. Two of them can-
celled participation after the baseline examination at Zurich,
and another 5 during the ascent to the Regina Margherita hut
due to symptoms of acute mountain sickness. Three of the
remaining 16 subjects (14 men, 2 women) had to spend an-
other night at the Gnifetti hut (3610 m) because of bad weather
conditions—of these, only data from the second, the third,
and the fourth night at the Regina Margherita hut were
available. Median age was 47 (quartile range 40 to 49) years,
the body mass index was 24 (22 to 28) kg/m2. Ten subjects
received dexamethasone starting 24 hours prior to ascent and
6 subjects received dexamethasone starting in the evening of
the second day at 4559 m.
Sleep studies
From a total of 77 study nights (one at 490 m and four at
4559 m per subject) 64 simultaneous polysomnographic and
actigraphic recordings were available for analysis. Thirteen
polysomnographies could not be used because of technical
failure or poor EEG/EMG signal quality. All actigraphies
could be evaluated and used for comparison. Sleep study
results are shown in Table 1.
Compared to the night at Zurich, polysomnograms revealed
that sleep was significantly impaired at altitude as reflected by
a greater time spent awake, a reduced amount of slow wave
sleep (NREM stages III and IV) and REM sleep, a reduced sleep
efficiency, and an increased arousal index (representative ex-
ample in Fig. 2). At altitude, there was a significant negative
correlation between the arousal index and sleep efficiency
measured by actigraphy as well as by polysomnography
(R= - 0.5, R= - 0.4, respectively; p< 0.05). Oxygen saturation
was significantly reduced at 4559 m and subjects revealed
pronounced periodic breathing with a very high central ap-
nea/hypopnea index. Since there were virtually no obstructive
events (< 5/h in all studies), these are not reported separately.
Comparsion of actigraphy to polysomnography
Actigraphic estimates of total sleep time and sleep effi-
ciency were similar to those of polysomnography (Table 1).
Overall median sleep latency by actigraphy did not signifi-
cantly differ from values assessed by polysomnography.
Figure 3 shows identity plots and plots of differences for total
sleep time and sleep efficiency estimated by actigraphy and
polysomnography. The numerical comparison is presented in
Table 2. There was no significant systematic error (bias) for
total sleep time, sleep efficiency, and sleep latency, with ex-
ception of a minor bias for sleep latency in the fourth night at
4559 m. The limits of agreement indicated that the precision of
actigraphy in estimation of total sleep time ( – 35 min corre-
sponding to – 9%) and sleep efficiency (– 7%) were high
(Table 2). Total sleep time and sleep efficiency from acti-
graphy were closely correlated with corresponding values by
polysomnography (R = 0.92, R= 0.82, respectively, p < 0.05)
while the correlation was poor for sleep latency (R = 0.14,
p =NS) (Table 2).
FIG. 2. The actigram obtained in a subject during a night at
490 m (top panel) shows very rare spikes with low activity
indicating nearly undisturbed sleep. Correspondingly, the
hypnogram (second panel from top) shows a normal distribu-
tion of sleep stages and four NREM/REM cycles. In contrast,
the actigram recorded during a night at 4559 m (third panel
from top) reveals frequent spikes of high activity reflecting
movements during the awakenings. The corresponding
hypnogram (lowest panel) reveals predominantly superficial
sleep stages with frequent awakenings, very rare deep sleep
stages 3 and 4, and no REM sleep. In addition to the awak-
enings the subject had a considerable number of arousals
(scored according to the ASDA 1992 criteria). Therefore,
sleep fragmentation was even more pronounced than what
can be appreciated in the hypnogram. X-axis, clock time;
y-axis of actigrams, acceleration in arbitrary units; y-axis of
hypnograms, NREM stages 1-4 and REM sleep. Lights off is
marked by a vertical arrow.
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The comparison of accelerations measured in a volun-
teer during 72 hours by the MSR actigraph used in the
current study and the Philips Respironics Actiwatch
Spectrum worn at the same wrist revealed a very close
correlation (R = 0.96, P < 10 - 6). Analysis of activity record-
ings obtained with the MSR actigraph used in the current
study were compared in 9 subjects during 29 nights with
the software developed for the current study and a com-
mercially available software (Actiware 5, Philips Re-
spironics,). The results revealed no significant bias in the
FIG. 3. Identity plots (left panels) and plots for differences of actigraphic minus polysomnographic estimates (ACT-PSG) vs.
their mean (right panels) for sleep efficiency (upper panels) and total sleep time (lower panels). Mean differences (bias) are
represented by a horizontal line and the limits of agreement (bias – 2 SD) by dashed lines.
Table 2. Comparison of Actigraphy to Polysomnography
R. Margherita hut 4559m
Total
Zurich 490m Night 1 Night 2 Night 3 Night 4 all nights
Number of comparisons 14 12 13 12 13 64
Total sleep time (min):
bias – limits of agreement 8.6 – 30.2 - 0.4 – 52.9 3.4 – 8.6 – 34.6 5.5 – 26.9 5.2 – 35
Correlation coefficient, R 0.78# 0.77# 20.3 0.97# 0.96# 0.92#
0.96#
Sleep efficiency (%):
bias – limits of agreement 2 – 6 0– 11 1– 4 2– 8 1– 5 1– 7
Correlation coefficient, R 0.75# 0.72# 0.96# 0.33 0.93# 0.82
Sleep latency (min), 3 min immobility:
median difference (quartiles) 0 - 0.5 1 0 - 3*{U - 1
Correlation coefficient, R ( - 7;3) (- 12.5;3) (- 4;2) ( - 3;1) ( - 23;0) (- 6;1.5)
- 0.29 0.49 0.35 0.53 - 0.21 0.14
Sleep latency (min), 5 min immobility:
median difference (quartiles) 2 1 1 1.5 - 1*{U 0
Correlation coefficient, R ( - 2;5) ( - 2.5;5) (- 1;4) (- 1.5;4) ( - 21;2) (- 4;4)
- 0.08 0.68# 0.28 0.23 - 0.2 0.13
Values represent mean differences (bias) of values by actigraphy minus corresponding values by polysomnography– 2SD (limits of
agreement). Since differences of sleep latency were not normally distributed medians (quartiles) are indicated instead of mean differences and
limits of agreement. Correlation analysis was performed using Spearman Rank Order testing. *p< 0.05 vs. 490 m, {p < 0.05 vs. night 2,
Up < 0.05 vs. night 3, #p < 0.05 polysomnography vs. actigraphy.
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estimated sleep time (mean difference of 4.0 min and limits
of agreement of – 24.9 min).
Symptoms and clinical examination
There was no significant overall effect of altitude on sub-
jective sleep quality. Subjective estimates of total time spent
awake at low and high altitude were significantly greater and
more variable than corresponding values measured by poly-
somnography (Fig. 4). At altitude, the Lake Louise Score in-
dicated that subjects suffered from mild symptoms of acute
mountain sickness (Table 3) but symptoms regressed during
prolonged stay. There was no significant correlation of the
subjective sleep quality measurement ‘restless sleep’ com-
pared to the sleep efficiency assessed by polysomnography
and actigraphy (R = 0.16 and 0.12, respectively, p=NS). Sub-
jective estimation of ‘nocturnal wakefulness’ also did not
correlate with the time spent awake measured by poly-
somnography or actigraphy (R = 0.18 and 0.21, respectively,
p =NS). However, there was a significant although weak
correlation between the arousal index and the Lake Louise
Score (R= 0.3, p< 0.05).
In two subjects, high altitude pulmonary edema developed
during the second night at altitude. They were initially treated
with sildenafil 50 mg and oxygen supplementation and re-
covered quickly with a treatment of sildenafil 25 mg twice
daily during the whole stay at altitude. No evacuation was
necessary, and sleep studies from these subjects were also
included into analysis.
Discussion
Our study validates a novel actimeter specifically designed
for field studies at altitude. Compared to polysomnography,
the gold standard for measuring sleep, actigraphy accurately
estimated the total sleep time and sleep efficiency, and it de-
tected changes in sleep efficiency induced by altitude. Sub-
jective perception of sleep quality and sleep duration did not
correlate with objective measures, emphasizing the need for
an objective tool assessing sleep at altitude. Since actigraphy is
unobtrusive and easily portable, it might serve as a valuable
tool for the investigation of the effects of altitude on sleep in
field studies over several days and nights.
Sleep studies at altitude can be simulated in pressure
chambers or performed under field conditions. Examinations
in the field are more realistic but are hampered by demanding
logistics, meteorological conditions, and the limited avail-
ability of polysomnography. Actigraphy is a simple and
convenient technique that allows estimating sleep/wakeful-
ness indirectly by recording movements of the wrist over
several months. The validity of actigraphic assessment of
sleep is supported by several studies in subjects with and
without sleep disturbances. De Souza et al. (2003) compared
actigraphy to polysomnography in 21 healthy volunteers.
Depending on the analysis algorithm applied, the bias and
limits of agreement for total sleep time were 18.5 – 41.4 min
and 8.1 – 42.0 min, respectively; the bias and limits of agree-
ment for sleep efficiency were 4– 8% and 2– 9%, respectively.
Gagnadoux et al. (2004) evaluated actigraphy in patients with
obstructive sleep apnea syndrome during a night in the sleep
laboratory without CPAP therapy. The bias of actigraphic
compared to polysomnographic estimates of total sleep time
was nonsignificant (2.5 min), however the precision was poor
as reflected in the very wide limit of agreement of – 70.6 min.
Gagnadoux and co-workers speculated that the poor perfor-
mance of actigraphy might have been due to the apnea-
related sleep fragmentation in obstructive sleep apnea patients
(Gagnadoux et al., 1999). In the current study, the precision of
actigraphy in terms of total sleep time and sleep efficiency was
greater and similar to that reported for normal subjects in
previous comparisons (Table 2) (De Souza et al., 2003). In
FIG. 4. Total time spent awake estimated subjectively (gray
bars) significantly exceeds corresponding values measured
by polysomnography (white bars) (*p < 0.05). Bars and vertical
lines represent medians and quartile ranges; the upper
quartile in night 3 was 350 min.
Table 3. Questionnaire Evaluation
R. Margherita hut, 4559m
Zurich, 490m Night 1 Night 2 Night 3 Night 4
Subjective sleep latency (min) 20{ (15;45) 30 (20;45) 20 (10;60) 25{ (20;90) 30 (12;45)
Subjective time spent awake (min) 60{ (30;60) 120*{ (60;180) 90{ (60;120) 135{ (60;350) 120{ (75;180)
SEQ ‘restless sleep’ 35 (24;42) 14 (5;24) 22 (11;38) 19 (6;36) 32 (22;42)
SEQ ‘wakefulness’ 18 (13;26) 13 (4;21) 20 (9;33) 21 (5;30) 29 (9;37)
SEQ ‘tired/alert’ 42 (35;49) 26 (15;48) 53# (46;64) 54 (28;63) 47 (40;59)
LLS total 0 (0;1) 4* (3;4) 3* (1;4) 2* (1;4) 2*# (1;3)
LLS question on insomnia 0 (0;0) 2* (1;3) 1* (1;2) 2* (1;2) 2* (1;2)
Medians (quartiles), n = 14. *p < 0.05 vs. 490 m, #p< 0.05 vs. night 1, {p< 0.05 vs. night 2, Up < 0.05 vs. night 3, {p < 0.05 vs. results from
polysomnography. LLS, Lake Louise score; SEQ, visual analog scores of Leeds Sleep Evaluation Questionnaire items.
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contrast to obstructive sleep apneas that commonly trigger
arousals, we observed that the proportion of central apneas
associated with arousals in high altitude periodic breathing
was low (Table 1) (Anholm et al. 1992, Khoo et al., 1996) which
might explain the better accuracy of actigraphy in the current
study in mountaineers.
Despite a nonsignificant bias, the sleep latency estimated
by actigraphy was only loosely correlated with polysomno-
graphic values (Table 2). This has been explained by a period
of immobility that precedes falling asleep and that might be
erroneously scored as sleep by actigraphy (Pollak et al., 2001).
In order to evaluate the potential effect of the analysis algo-
rithm on sleep latency estimated by actigraphy (Chae et al.,
2009), we applied a 5 minutes and a 3 minutes immobility rule
for sleep onset and found no clinically relevant difference in
resulting sleep latencies (Table 1).
The close correlation of acceleration measured by the acti-
graph used in the current study and another commercially
available device, and the lack of a significant bias between
estimates of sleep time obtained by our specialized software
and a commercially available software suggest that evalua-
tion of sleep time at altitude may be performed by the acti-
graph and software used in the current study and at least one
other type of equipment. We cannot exclude that other acti-
meters may perform differently or may not be robust enough
for field studies at altitude. Therefore, a careful selection and
evaluation of the actigraphic equipment is crucial.
We observed that subjects perceived their sleep quality at
high altitude as poor and polysomnography revealed a re-
duced amount of slow wave and REM sleep (Table 1). Only
few studies have investigated sleep at altitude using poly-
somnography and the variety of applied protocols including
differences in ascent rate, acclimatization, sleeping altitude,
and settings hampers a comparison to the current data.
Nevertheless, a reduced deep sleep seems to be a consistent
finding ( Johnson et al., (2010); Nussbaumer-Ochsner et al.,
2010). The arousal indices we measured at low and high al-
titude were relatively low, in particular considering the high
apnea/hypopnea index at 4559 m (Table 1). Since the few
published studies on the arousal index in healthy subjects of
different age groups reveal a very large normal range (Mathur
et al., 1995), it remains open whether our findings are spurious
due to the shortcomings of a single central EEG recording,
whether arousals defined by the ASDA criteria (American
Sleep Disorders Association Task Force, 1992) do not reflect
sleep disturbance from high altitude periodic breathing, or
whether HAPE-susceptible subjects have an altered arousal
response. Finally, we were not able to assess the effects of
dexamethasone which may have modified the arousal
threshold.
While the current study is the first that validates actigraphy
by comparison to polysomnography at altitude, the technique
has been employed previously to evaluate the effects of
hypoxia, acute mountain sickness, and drugs for treatment of
altitude insomnia (Barash et al., 2001; Erba et al., 2004; Nickol
et al., 2006) illustrating the role of actigraphy for investigation
of sleep and its disturbances at altitude. One study revealed
that temazepam induced a reduction in periodic breathing
over the course of a trek to 5000 m (Nickol et al., 2006) but
there was no change in actigraphic sleep latency or nocturnal
restlessness. Another study assessing the effects of zolpidem
and zaleplon on sleep at 3613 m (Beaumont et al., 2007) re-
vealed a significant decrease in the number of wrist move-
ments by both drugs compared to placebo. Barash et al. (2001)
evaluated the effect of oxygen enrichment on sleep architec-
ture at 3800 m. Compared to ambient air, no significant dif-
ference for sleep efficiency, time scored awake and asleep was
detected by actigraphy. Polysomnography showed that sub-
jects spent a significantly greater percentage of time in deep
sleep stages (slow wave sleep) with oxygen enrichment, while
no change in the other sleep variables was detected. In an-
other study at altitude, we compared sleep and nocturnal
breathing in subjects with and without acute mountain sick-
ness (Erba et al., 2004). Actigraphic recordings indicated re-
duced sleep efficiency in subjects suffering from acute
mountain sickness consistent with the notion that insomnia
and headache are characteristic features of the disease.
The lack of a correlation between subjective estimates of total
sleep time and sleep latency with corresponding measure-
ments by polysomnography (Table 3, Fig. 4) may represent a
sleep state misperception and emphasizes the important role of
objective measurements for assessing sleep at altitude.
Although total sleep time and sleep efficiency estimated by
actigraphy and polysomnographic variables reflecting sleep
architecture represent useful information for assessment of
sleep disturbances at altitude, it is conceivable that multi-
channel, topographic EEG and other measures yet to be de-
fined by future studies might be more sensitive and specific
for assessment of altitude effects on sleep.
Conclusion
Our study demonstrates that actigraphy provides objective
estimates of sleep efficiency and total sleep time at low and
high altitude which are sufficiently accurate to be of use in
research studies. Considering its simple use and robustness
and the potential application over several weeks makes the
technique a valuable tool for investigation of sleep distur-
bance during altitude field studies. Actigraphy might be used
as an adjunct to questionnaire evaluation and clinical exami-
nation in settings were more sophisticated methods such as
polysomnography cannot be used.
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